Ligand validation:8S6Z

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8S6Z_IMD_A_301	73%	84%	0.112	0.939	0.23	0.53	-	-	0	0	100%	1
8S6Z_IMD_E_301	63%	76%	0.083	0.878	0.28	0.66	-	-	0	0	100%	1
8S6Z_IMD_D_301	38%	79%	0.14	0.839	0.24	0.62	-	-	0	0	100%	1
8S6Z_IMD_B_302	11%	82%	0.177	0.695	0.24	0.56	-	-	0	0	100%	1
8S6Z_IMD_B_303	2%	78%	0.235	0.536	0.24	0.65	-	-	0	0	100%	1
8S6Z_IMD_F_206	1%	81%	0.274	0.467	0.14	0.66	-	-	0	0	100%	1
8S6Z_IMD_C_206	1%	80%	0.288	0.479	0.13	0.69	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.